STA9090: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer.

Trial Profile

STA9090: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Feb 2016

At a glance

  • Drugs Ganetespib (Primary) ; Capecitabine
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 May 2015 Interim results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 28 May 2015 According to a Synta Pharmaceuticals media release, data from this trial will be presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top